Ledger.Open graph →
SEC Form D · filed February 27, 2019

Oyster Point Pharma, Inc

Offering
$93.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PRINCETON, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

William J. Link · San Francisco, CADirectorClare A. Ozawa · Princeton, NJDirectorAli J. Behbahani · San Francisco, CADirectorD. M. Ackermann · San Francisco, CADirectorBenjamin A. Tsai · Princeton, NJDirectorJeffrey A. Nau · San Francisco, CAExec · DirectorMark A. Murray · San Francisco, CAExec · DirectorWilliam J. Link · San Francisco, CADirectorD. M. Ackermann · San Francisco, CADirectorClare A. Ozawa · Princeton, NJDirectorBenjamin A. Tsai · Princeton, NJDirectorAli J. Behbahani · San Francisco, CADirectorJeffrey A. Nau · San Francisco, CAExec · DirectorMark A. Murray · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗